BFEC
NARI

Benjamin F. Edwards & Company’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Benjamin F. Edwards & Company’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$89K Buy
1,847
+522
+39% +$23.1K ﹤0.01% 1140
2024
Q1 		$64K Buy
1,325
+227
+21% +$12.1K ﹤0.01% 1230
2023
Q4 		$71K Buy
1,098
+236
+27% +$14.2K ﹤0.01% 1172
2023
Q3 		$56K Hold
862
– – ﹤0.01% 1047
2023
Q2 		$50K Hold
862
– – ﹤0.01% 1091
2023
Q1 		$53K Sell
862
-90
-9% -$5.4K ﹤0.01% 1081
2022
Q4 		$61K Hold
952
– – ﹤0.01% 1031
2022
Q3 		$69K Sell
952
-75
-7% -$5.58K ﹤0.01% 967
2022
Q2 		$70K Sell
1,027
-365
-26% -$26.2K ﹤0.01% 965
2022
Q1 		$126K Sell
1,392
-121
-8% -$9.9K 0.01% 814
2021
Q4 		$138K Sell
1,513
-10
-0.7% -$857 0.01% 805
2021
Q3 		$124K Sell
1,523
-14
-0.9% -$1.18K 0.01% 799
2021
Q2 		$143K Hold
1,537
– – 0.01% 744
2021
Q1 		$164K Sell
1,537
-173
-10% -$17.9K 0.01% 723
2020
Q4 		$149K Sell
1,710
-385
-18% -$27.2K 0.01% 720
2020
Q3 		$145K Buy
+2,095
New +$135K 0.01% 668

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Benjamin F. Edwards & Company's NARI Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Inari Medical, Inc. Common Stock (NARI) stake by 39% in Q2 2024, buying an estimated $23.1K and bringing the position to 1,847 shares worth $89K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Benjamin F. Edwards & Company first reported a position in NARI in Q3 2020 and has held it in 16 quarters since. The position peaked at $164K in Q1 2021. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Benjamin F. Edwards & Company held 1,847 shares of Inari Medical, Inc. Common Stock worth $89K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 522 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $23.1K.
  • Inari Medical, Inc. Common Stock made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1140 holding.
  • Benjamin F. Edwards & Company first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and has held it in 16 quarters since.
  • Benjamin F. Edwards & Company's Inari Medical, Inc. Common Stock position peaked at $164K in Q1 2021.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.